Home » Topics » Regulatory

Regulatory
RSS

Glivec approved in E.U. for additional cancer indications

Sep. 19, 2006

FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus

Sep. 19, 2006

German approval for Foster in asthma

Aug. 31, 2006

Keppra receives FDA approval for juvenile myoclonic epilepsy

Aug. 24, 2006

CE Mark for Repel-CV to reduce adhesions following cardiac surgery

Aug. 24, 2006

Mexico first to approve Januvia

Aug. 9, 2006

ATryn approved for use in E.U.

Aug. 3, 2006

Xolegel approved for seborrheic dermatitis

July 31, 2006

Famvir approved for recurrent genital herpes and cold sores

July 31, 2006

duetact approved for type 2 diabetes

July 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 25, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Gene therapy efforts active, despite low Bluebird, 2seventy bids
BioWorld
Bristol Myers Squibb Co.’s decision this week to snag Bluebird Bio Inc. spinout 2seventy Bio Inc. for $102 million net – just weeks after investors bid $30...
US NIH grant peer review to get a bit of a makeover
BioWorld
Looking to shave $65 million from its annual expenditures while streamlining the first stage of its two-level grant review process, the U.S. NIH is proposing to...